Samsung Medical Center/Division of Nephrology
About Samsung Medical Center/Division of Nephrology
Samsung Medical Center is a tertiary hospital located in Irwon-Dong of Gangnam-Gu, Seoul, South Korea. SMC is composed of Samsung Seoul Hospital, Kangbook Samsung Hospital, Samsung Changwon Hospital, and Samsung Life Sciences Research Center. SMC was founded on November 9, 1994.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Samsung Medical Center/Division of Nephrology
During the past decade, Samsung Medical Center/Division of Nephrology conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Adjuvant Hormone Therapy in Treating Women With Operable Breast Cancer
1987-09-01
Unknown status
Radiation Therapy With and Without Combination Chemotherapy in Patients With Resected Anaplastic Oligodendroglioma
1996-08-01
Completed
350
Radiation Therapy Compared With Chemotherapy in Treating Patients With Stage I Testicular Cancer
1998-04-01
2005-07-01
Completed
800
Fluorouracil in Treating Patients With Recurrent or Metastatic Bladder Cancer
1997-12-01
2009-03-01
Completed
45
Combination Chemotherapy With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma
1999-05-01
2017-07-19
Completed
475
Chemotherapy in Treating Patients With Newly Diagnosed Chronic Lymphocytic Leukemia
1999-10-01
2007-07-01
Completed
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Samsung Medical Center/Division of Nephrology
According to Clinical.Site data, the most researched conditions in "Samsung Medical Center/Division of Nephrology" are
"Diabetic Nephropathies" (1 trials) and "Polycystic Kidney, Autosomal Dominant" (1 trials). Many other conditions were trialed in "Samsung Medical Center/Division of Nephrology" in a lesser frequency.
Clinical Trials Intervention Types at Samsung Medical Center/Division of Nephrology
Most popular intervention types in "Samsung Medical Center/Division of Nephrology" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (2 trials), "Bosutinib" (1 trials) and "PF-00489791" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Samsung Medical Center/Division of Nephrology
The vast majority of trials in "Samsung Medical Center/Division of Nephrology" are
2 trials for "All" genders.
Clinical Trials Status at Samsung Medical Center/Division of Nephrology
Currently, there are NaN active trials in "Samsung Medical Center/Division of Nephrology".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Samsung Medical Center/Division of Nephrology,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Samsung Medical Center/Division of Nephrology, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".